Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.,The Lancet

当前位置： X-MOL 学术 › Lancet › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
The Lancet ( IF 168.9 ) Pub Date : 2017-Nov-25 , DOI: 10.1016/s0140-6736(17)32400-5
Denice S Feig ₁ , Lois E Donovan ₂ , Rosa Corcoy ₃ , Kellie E Murphy ₄ , Stephanie A Amiel ₅ , Katharine F Hunt ₆ , Elizabeth Asztalos ₇ , Jon F R Barrett ₇ , J Johanna Sanchez ₇ , Alberto de Leiva ₃ , Moshe Hod ₈ , Lois Jovanovic ₉ , Erin Keely ₁₀ , Ruth McManus ₁₁ , Eileen K Hutton ₁₂ , Claire L Meek ₁₃ , Zoe A Stewart ₁₃ , Tim Wysocki ₁₄ , Robert O'Brien ₁₅ , Katrina Ruedy ₁₅ , Craig Kollman ₁₅ , George Tomlinson ₁₆ , Helen R Murphy ₁₇ ,

Affiliation

Department of Medicine, Sinai Health System, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Department of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau CIBER-BBN, Barcelona, Spain.
Department of Obstetrics & Gynecology, Sinai Health System, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Diabetes Research Group, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Diabetes Research Group, Faculty of Life Sciences and Medicine, King's College London, London, UK; Diabetes Service, Devision of Urgent Care, Planned Care and Allied Critical Services, King's College Hospital NHS Foundation Trust, London, UK.
Sunnybrook Research Institute, Toronto, ON, Canada.
Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petah, Tikvah, Israel.
Division of Endocrinology, University of Southern California, Los Angeles, CA, USA; Department of Chemistry, University of California, Santa Barbara, CA, USA.
Department of Medicine, University of Ottawa, and The Ottawa Hospital, Ottawa, ON, Canada.
Department of Medicine, St Joseph Health Care London, ON, Canada; Department of Medicine, University of Western ON, London, ON, Canada.
Department of Obstetrics & Gynecology, McMaster University Hamilton, ON, Canada.
Wolfson Diabetes and Endocrine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Nemours Children's Health System, Jacksonville, FL, USA.
Jaeb Center For Health Research, Tampa, FL, USA.
Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Medicine, University Health Network, Toronto, ON, Canada.
Department of Women and Children's Health, St Thomas' Hospital, King's College London, London, UK; Wolfson Diabetes and Endocrine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Medicine, University of East Anglia, Norwich, UK.

Pregnant women with type 1 diabetes are a high-risk population who are recommended to strive for optimal glucose control, but neonatal outcomes attributed to maternal hyperglycaemia remain suboptimal. Our aim was to examine the effectiveness of continuous glucose monitoring (CGM) on maternal glucose control and obstetric and neonatal health outcomes.

中文翻译：